Development of regional programs to speed treatment of stroke.

  title={Development of regional programs to speed treatment of stroke.},
  author={Jeffrey A. Switzer and David C. Hess},
  journal={Current neurology and neuroscience reports},
  volume={8 1},
The pathophysiology of ischemic stroke dictates that treatments be administered shortly after symptom onset to be beneficial. Intravenous tissue plasminogen activator is the only drug proven to be effective in stroke; it is approved for administration within a 3-hour window. To optimize the number of potential candidates for thrombolytic therapy, patients… CONTINUE READING